Smith & Nephew plc (LON:SN)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1,200.50
-9.50 (-0.79%)
At close: Jan 20, 2026
17.06%
Market Cap10.20B
Revenue (ttm)4.33B
Net Income (ttm)358.03M
Shares Out849.76M
EPS (ttm)0.41
PE Ratio29.50
Forward PE14.69
Dividend0.28 (2.34%)
Ex-Dividend DateOct 2, 2025
Volume2,433,842
Average Volume2,556,203
Open1,207.50
Previous Close1,210.00
Day's Range1,193.50 - 1,211.00
52-Week Range937.80 - 1,441.50
Beta0.64
RSI40.10
Earnings DateMar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced... [Read more]

Sector Healthcare
Founded 1856
Employees 17,349
Stock Exchange London Stock Exchange
Ticker Symbol SN
Full Company Profile

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD Financial Statements

News

Lightning Round: Medline is 'unbelievable', it's a buy, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: Medline, Super Micro Computers, Alkermes, Oscar Health, UiPath, Constellation Energy Corp., Smith & Nephew, and more.

4 days ago - CNBC

Notable Two Hundred Day Moving Average Cross - SNN

In trading on Tuesday, shares of Smith & Nephew plc (Symbol: SNN) crossed below their 200 day moving average of $32.34, changing hands as low as $32.16 per share. Smith & Nephew plc shares are current...

7 days ago - Nasdaq

Smith & Nephew PLC (SNN) Trading Down 4.57% on Jan 13

Smith & Nephew PLC (SNN) Trading Down 4.57% on Jan 13

7 days ago - GuruFocus

UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million

British medical products maker Smith & Nephew will buy U.S.-based Integrity Orthopaedics in a deal that could be valued at up to $450 million, the company said on Monday.

8 days ago - Reuters

Smith & Nephew plc (SNN) Analyst/Investor Day Transcript

Smith & Nephew plc (SNN) Analyst/Investor Day Transcript

5 weeks ago - Seeking Alpha

Anglo American’s merger bonus was a pay wheeze too far | Nils Pratley

Miner will have to do things by the book after ditching plan to pay bosses millions in bonuses after Teck deal Anglo American drops plan to pay bosses millions in bonuses Shareholder rebellions over e...

6 weeks ago - The Guardian

UK Stock Market News: Smith & Nephew, Unilever, Oxford Nanopore

Smith & Nephew unveils RISE strategy with upgraded guidance, Unilever completes ice cream demerger, Oxford Nanopore names veteran CEO

6 weeks ago - The Armchair Trader

Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets

British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million and unveiled new medium-term targets ahead of its Capital Markets Day Event on Monday.

6 weeks ago - Reuters

Smith & Nephew (SNN) Analyst Rating Update: Target Price Lowered | SNN Stock News

Smith & Nephew (SNN) Analyst Rating Update: Target Price Lowered | SNN Stock News

2 months ago - GuruFocus

Smith & Nephew is Now Oversold (SNN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...

2 months ago - Nasdaq

Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release

Discover why Smith & Nephew (SNN) earns a 'Hold' rating amid valuation concerns and resistance levels. Click here to read my analysis of Smith & Nephew stock.

2 months ago - Seeking Alpha

Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound thera...

3 months ago - GlobeNewsWire

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts or...

3 months ago - GlobeNewsWire

Smith & Nephew (SNN) Downgraded to 'Market Perform' by Bernstein | SNN Stock News

Smith & Nephew (SNN) Downgraded to 'Market Perform' by Bernstein | SNN Stock News

3 months ago - GuruFocus

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound ...

3 months ago - GlobeNewsWire

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the laun...

3 months ago - GlobeNewsWire

Ex-Dividend Reminder: ESAB, Sylvamo and Smith & Nephew

Looking at the universe of stocks we cover at Dividend Channel, on 10/3/25, ESAB Corp (Symbol: ESAB), Sylvamo Corp (Symbol: SLVM), and Smith & Nephew plc (Symbol: SNN) will all trade ex-dividend for t...

3 months ago - Nasdaq

Smith & Nephew Reaches Analyst Target Price

In recent trading, shares of Smith & Nephew plc (Symbol: SNN) have crossed above the average analyst 12-month target price of $35.55, changing hands for $36.29/share. When a stock reaches the target a...

3 months ago - Nasdaq

Smith & Nephew (SNN) CFO Relocates to U.S. to Drive Growth

Smith & Nephew (SNN) CFO Relocates to U.S. to Drive Growth

4 months ago - GuruFocus